Fortin JS, Chlipala EA, Shaw DP, Bolon B. Methods optimization for routine sciatic nerve processing. Toxicologic Pathology, special 2020 issue focusing on PNS Toxicologic Neuropathology. In press (April 15, 2019).

Fortin JS, Benoit-Biancamano M-O, C-Gaudreault R. Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide formation and cytotoxicity. Can J Physiol Pharmacol. 2016;94(3):341-6.

Fortin JS, Benoit-Biancamano M-O. Inhibition of islet amyloid polypeptide (IAPP) aggregation and associated cytotoxicity by Non-steroidal Anti-Inflammatory Drugs (NSAIDs). Can J Physiol Pharmacol. 2016;94(1):35-48.

Fortin JS, Benoit-Biancamano M-O. Wildlife sequences of islet amyloid polypeptide (IAPP) identify critical mutations for fibrillization. Amyloid. 2015;22(3):194-202.

Fortin JS, Benoit-Biancamano M-O. In vitro evaluation of oral hypoglycaemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and β-cell loss. Can J Diabetes. 2015; 39(5):373-82.

Qin Y, Fortin JS, Tye D, Guzman M, Hurley LH. Molecular cloning of the human PDGFR-b promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-b expression. Biochemistry. 2010;49(19):4208-19.

Fortin JS, Côté M-F, Lacroix J, Desjardin M, Petitclerc E, C-Gaudreault R. Selective alkylation of bII-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading either to anti-microtubule or redox modulating agents. Bioorg Med Chem. 2008;16(15):7277-90. Featured in DailyUpdates/LeadDiscovery headline articles.

Fortin JS, Côté M-F, Lacroix J, Petitclerc E, C-Gaudreault R. Aromatic 2-chloroethyl urea derivatives and bioisosteres. Part 2: cytocidal activity and effects on the nuclear translocation of thioredoxin-1, and the cell cycle progression. Bioorg Med Chem. 2008;16(15):7477-88. Featured in DailyUpdates/LeadDiscovery headline articles.

Fortin JS, Côté M-F, Lacroix J, Patenaude A, Petitclerc E, C-Gaudreault R. Cycloalkyl-substituted aryl chloroethylureas inhibiting cell cycle progression in G0/G1 phase and thioredoxin-1 nuclear translocation. Bioorg Med Chem Lett. 2008;18(12):3526-31.

Fortin JS, Lacroix J, Desjardins M, Patenaude A, Petitclerc E, C-Gaudreault R. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site. Bioorg Med Chem. 2007;15(13):4456-69. Featured in DailyUpdates/LeadDiscovery headline articles.